FDA details timeframe of MS drug Tysabri's risks | Reuters
Links shared publicly online about this topic.
- 343total visits
FDA details timeframe of MS drug Tysabri's risks | Reuters
View full resource at reuters.com
Tags: Infection, Brain, Encephalitis, Multiple Sclerosis Medication, Drug, FDA, Tysabri
Most Recently Shared on April 24, 2011 at 12:20 am By:
FDA details timeframe of MS drug Tysabri's risks http://reut.rs/hpYerO
FDA details timeframe of MS drug Tysabri's risks | Reuters
reuters.com — “WASHINGTON (Reuters) - The brain infection risk from Biogen Idec's multiple sclerosis drug Tysabri appears highest during the third year of treatment, U.S. health officials said in an updated warning released” View full resource at reuters.com
Most Recently Shared on April 23, 2011 at 8:10 am By:
FDA details timeframe of MS drug Tysabri's risks http://reut.rs/dK0oZb
FDA details timeframe of MS drug Tysabri's risks | Reuters
reuters.com — “WASHINGTON (Reuters) - The brain infection risk from Biogen Idec's multiple sclerosis drug Tysabri appears highest during the third year of treatment, U.S. health officials said in an updated warning released” View full resource at reuters.com
Most Recently Shared on April 22, 2011 at 10:36 pm By:
Gannett Healthcare Health News
FDA details timeframe of MS drug Tysabri's risks http://reut.rs/gGhW8w
FDA details timeframe of MS drug Tysabri's risks | Reuters
reuters.com — “WASHINGTON (Reuters) - The brain infection risk from Biogen Idec's multiple sclerosis drug Tysabri appears highest during the third year of treatment, U.S. health officials said in an updated warning released” View full resource at reuters.com
Most Recently Shared on April 22, 2011 at 10:00 pm By:
Ryan Madanick, MD Doctor, Internist, Gastroenterologist, and Physician
also a drug for #Crohns >> RT “@hrana: News: #FDA details timeframe of MS drug Tysabri's risks http://t.co/hASEhhn - #health #pharma†#IBD
FDA details timeframe of MS drug Tysabri's risks | Reuters
reuters.com — “WASHINGTON (Reuters) - The brain infection risk from Biogen Idec's multiple sclerosis drug Tysabri appears highest during the third year of treatment, U.S. health officials said in an updated warning released” View full resource at reuters.com
Most Recently Shared on April 22, 2011 at 9:40 pm By:
Brad Lipson, DO Doctor, Family Medicine Doctor, Physician, and Active Health Library
FDA details timeframe of MS drug Tysabri's risks: WASHINGTON (Reuters) - The brain infection risk from Bio... http://tinyurl.com/3mvad5m
FDA details timeframe of MS drug Tysabri's risks | Reuters
reuters.com — “WASHINGTON (Reuters) - The brain infection risk from Biogen Idec's multiple sclerosis drug Tysabri appears highest during the third year of treatment, U.S. health officials said in an updated warning released” View full resource at reuters.com
Most Recently Shared on April 22, 2011 at 7:26 pm By:
FDA details timeframe of MS drug Tysabri's risks: WASHINGTON (Reuters) - The brain infection risk from Biogen Id... http://bit.ly/g2L78K
FDA details timeframe of MS drug Tysabri's risks | Reuters
reuters.com — “WASHINGTON (Reuters) - The brain infection risk from Biogen Idec's multiple sclerosis drug Tysabri appears highest during the third year of treatment, U.S. health officials said in an updated warning released” View full resource at reuters.com
Most Recently Shared on April 22, 2011 at 7:18 pm By:
FDA details timeframe of MS drug Tysabri's risks http://bit.ly/eCk9tO
FDA details timeframe of MS drug Tysabri's risks | Reuters
reuters.com — “WASHINGTON (Reuters) - The brain infection risk from Biogen Idec's multiple sclerosis drug Tysabri appears highest during the third year of treatment, U.S. health officials said in an updated warning released” View full resource at reuters.com
Most Recently Shared on April 22, 2011 at 7:04 pm By:
FDA details timeframe of MS drug Tysabri's risks: WASHINGTON (Reuters) - The brain infection risk ... http://bit.ly/ho9lEZ #health #news
FDA details timeframe of MS drug Tysabri's risks | Reuters
reuters.com — “WASHINGTON (Reuters) - The brain infection risk from Biogen Idec's multiple sclerosis drug Tysabri appears highest during the third year of treatment, U.S. health officials said in an updated warning released” View full resource at reuters.com
Most Recently Shared on April 22, 2011 at 7:04 pm By:
HealthIT Policy Health IT and Health News
FDA details timeframe of MS drug Tysabri's risks: WASHINGTON (Reuters) - The brain infection risk from Biogen Id... http://bit.ly/e2jSEN
FDA details timeframe of MS drug Tysabri's risks | Reuters
reuters.com — “WASHINGTON (Reuters) - The brain infection risk from Biogen Idec's multiple sclerosis drug Tysabri appears highest during the third year of treatment, U.S. health officials said in an updated warning released” View full resource at reuters.com
Most Recently Shared on April 22, 2011 at 5:59 pm By:
FDA details timeframe of Biogen MS drug's risks: WASHINGTON (Reuters) - The brain infection risk f... http://bit.ly/gyvdPc #health #news
FDA details timeframe of MS drug Tysabri's risks | Reuters
reuters.com — “WASHINGTON (Reuters) - The brain infection risk from Biogen Idec's multiple sclerosis drug Tysabri appears highest during the third year of treatment, U.S. health officials said in an updated warning released” View full resource at reuters.com
Most Recently Shared on April 22, 2011 at 5:42 pm By:
FDA details timeframe of Biogen MS drug's risks: WASHINGTON (Reuters) - The brain infection risk from Biogen Ide... http://bit.ly/g1YKdn
FDA details timeframe of MS drug Tysabri's risks | Reuters
reuters.com — “WASHINGTON (Reuters) - The brain infection risk from Biogen Idec's multiple sclerosis drug Tysabri appears highest during the third year of treatment, U.S. health officials said in an updated warning released” View full resource at reuters.com
Most Recently Shared on April 22, 2011 at 5:40 pm By:
Brad Lipson, DO Doctor, Family Medicine Doctor, Physician, and Active Health Library
FDA details timeframe of Biogen MS drug's risks: WASHINGTON (Reuters) - The brain infection risk from Biog... http://tinyurl.com/3r75hjs
FDA details timeframe of MS drug Tysabri's risks | Reuters
reuters.com — “WASHINGTON (Reuters) - The brain infection risk from Biogen Idec's multiple sclerosis drug Tysabri appears highest during the third year of treatment, U.S. health officials said in an updated warning released” View full resource at reuters.com
Most Recently Shared on April 22, 2011 at 4:36 pm By:
FDA reports on brain infections with MS drug Tysabri http://bit.ly/i1VSHB
FDA details timeframe of MS drug Tysabri's risks | Reuters
reuters.com — “WASHINGTON (Reuters) - The brain infection risk from Biogen Idec's multiple sclerosis drug Tysabri appears highest during the third year of treatment, U.S. health officials said in an updated warning released” View full resource at reuters.com
Most Recently Shared on April 22, 2011 at 4:29 pm By:
FDA reports on brain infections with MS drug Tysabri: WASHINGTON (Reuters) - More than 100 cases of a potentiall... http://bit.ly/gjJMhL
FDA details timeframe of MS drug Tysabri's risks | Reuters
reuters.com — “WASHINGTON (Reuters) - The brain infection risk from Biogen Idec's multiple sclerosis drug Tysabri appears highest during the third year of treatment, U.S. health officials said in an updated warning released” View full resource at reuters.com
Most Recently Shared on April 22, 2011 at 4:23 pm By:
FDA reports on brain infections with MS drug Tysabri: WASHINGTON (Reuters) - More than 100 cases o... http://bit.ly/i3C619 #health #news
Advertisement
